Catalent
CTLT
#1589
Rank
NZ$18.24 B
Marketcap
$100.54
Share price
0.20%
Change (1 day)
52.08%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Market capitalization of Catalent (CTLT)

Market cap: NZ$18.24 Billion

As of November 2024 Catalent has a market cap of NZ$18.24 Billion. This makes Catalent the world's 1589th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Catalent from 2014 to 2024

End of year Market Cap

Year Marketcap Change
2024NZ$18.24 B42.2%
2023NZ$12.83 B0.59%
2022NZ$12.75 B-61.97%
2021NZ$33.55 B41.24%
2020NZ$23.75 B94.1%
2019NZ$12.23 B80.8%
2018NZ$6.76 B-11.92%
2017NZ$7.68 B58.28%
2016NZ$4.85 B6.62%
2015NZ$4.55 B3.37%
2014NZ$4.40 B

End of Day market cap according to different sources

On Nov 20th, 2024 the market cap of Catalent was reported to be:

NZ$18.24 Billion
by Nasdaq info icon info icon
NZ$18.24 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
NZ$3.39 B-81.38%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.28 B-92.96%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$12.28 B-32.69%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
NZ$1.35 B-92.58%๐Ÿ‡บ๐Ÿ‡ธ USA